UNH
Strong BuyFull HouseFLAGUnitedHealth Group Incorporated · Healthcare · United States · $352.7B · Avg Vol: $1.8B/d
Full House: Strong business, sensible price, market agrees. The rare full house.
UnitedHealth Group has strong momentum at M75 with a buyback on file, but value at V44 is below the calibrated floor and quality Q59 is offset, so stage one fails.
The ranks quoted here are from the day it was written; today's Quality, Value and Momentum are the bars above.
ABOUT UNITEDHEALTH GROUP INCORPORATED
Read
UnitedHealth Group is the largest diversified healthcare company, encompassing UnitedHealthcare, a leading health benefits provider, and Optum, which delivers technology-enabled health services. Its wide competitive moat stems from immense scale, a vast network of providers and members, and the significant data and cost advantages derived from its vertically integrated Optum segment. UnitedHealth Group is a dominant force in both health insurance and health services, strategically positioned for continued growth.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 324.2B | 371.6B | 400.3B | 447.6B | 11.4% | 450.5B | 446.5B | 459.4B | 1.3% |
| EPS | 21.54 | 24.22 | 15.74 | 13.31 | -14.8% | 15.57 | 16.13 | 18.26 | 17.1% |
| Shares | 934.0M | 924.0M | 915.0M | 905.8M | -3.0% | 897.6M | — | — | — |
| Debt | 57.6B | 62.5B | 76.9B | 78.4B | 10.8% | 73.3B | — | — | — |
| Equity | 77.8B | 88.8B | 92.7B | 94.1B | 6.6% | — | — | — | — |
| Op CF | 26.2B | 29.1B | 24.2B | 19.7B | -9.1% | 27.0B | — | — | — |
| Inv CF | -28.5B | -15.6B | -20.5B | -8.7B | — | — | — | — | — |
| Fin CF | 4.2B | -11.5B | -3.5B | -11.6B | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of UNH are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| UNH | UnitedHealth Group Incorporated(you) | $352.7B | 90 | Strong Buy |
| CVS | CVS Health Corporation | $119.0B | 93 | Strong Buy |
| ELV | Elevance Health, Inc. | $85.5B | 90 | Strong Buy |
| CI | The Cigna Group | $73.7B | 92 | Strong Buy |
| HUM | Humana Inc. | $46.3B | 89 | Strong Buy |
| CNC | Centene Corporation | $32.0B | 93 | Strong Buy |
| OSCR | Oscar Health, Inc. | $9.4B | 98 | Strong Buy |
| SAUD3.SA | Bradsaúde S.A. | $7.9B | 98 | Strong Buy |
| MOH | Molina Healthcare, Inc. | $10.4B | 71 | Buy |
| ROP.SW | Roche Holding AG | $353.1B | 88 | Strong Buy |
Peer medians: ROE 2.7% · P/E 23.5x · Gross margin 52.5%
Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.